
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Bachrach, Pediatric Endocrinologist in Palo Alto, CA?
Dr. Laura Bachrach, MD is a Pediatric Endocrinologist, who primarily practices in Palo Alto, CA with 1 additional practice location. She is board certified. Dr. Bachrach completed her residency at Stanford Univ Hosp, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics. Dr. Bachrach is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Bachrach’s office at (408) 885-5000.
What are Areas of Expertise for Dr. Bachrach?
Dr. Laura Bachrach, MD is a highly-rated, board-certified Pediatric Endocrinologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Bachrach empowers patients to confidently navigate their health journey, specializing in Diabetes, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Bachrach is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Bachrach go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics
Medical School: Tufts Univ Sch of Med, Boston Ma
Is Dr. Bachrach board certified as a Pediatric Endocrinologist?
Yes, Dr. Laura Bachrach, MD is board certified by the American Board of Pediatrics
What languages does Dr. Bachrach speak?
Dr. Bachrach and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Pediatric Endocrinologist like Dr. Bachrach typically treat?
As a Pediatric Endocrinologist, Dr. Bachrach diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Bachrach. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Congenital Hypothyroidism
- Other Hypothyroidism
- Hypothyroidism
- Congenital hypothyroidism
- Underactive Thyroid at Birth
- Neonatal Hypothyroidism
- Underactive Thyroid
- Low Thyroid Function
- Thyroid Gland Underactivity
ICD-10 Codes:
- E031: Congenital hypothyroidism without goiter
- E038: Other specified hypothyroidism
Also known as:
- Short Stature in Children
- Growth Disorder
- Child Growth Problems
- Dwarfism
- Growth Retardation
ICD-10 Codes:
- R6252: Short stature (child)
Also known as:
- Early Puberty
- Puberty
- Central precocious puberty
- Precocious puberty
- Puberty at a young age
ICD-10 Codes:
- E301: Precocious puberty
Also known as:
- Underactive Pituitary Gland
- Pituitary Disorder
- Combined pituitary hormone deficiency
- Isolated growth hormone deficiency
- Hypopituitarism
- Pituitary Hormone Deficiency
- Low Pituitary Function
ICD-10 Codes:
- E230: Hypopituitarism
Also known as:
- Osteogenesis Imperfecta
- Dentinogenesis imperfecta
- Brittle bone disease
- OI
- Fragile bones
ICD-10 Codes:
- Q780: Osteogenesis imperfecta
Also known as:
- Graves' Disease
- Hyperthyroidism
- Graves' disease
- Graves Disease
- Hyperthyroidism with Goiter
- Toxic Diffuse Goiter
- Overactive Thyroid with Enlarged Gland
ICD-10 Codes:
- E0500: Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm
Also known as:
- Hashimoto's Disease
- Thyroid Disease
- Hashimoto's disease
- Autoimmune thyroiditis
- Chronic lymphocytic thyroiditis
- Hashimoto's thyroiditis
ICD-10 Codes:
- E063: Autoimmune thyroiditis
What procedures does a Pediatric Endocrinologist like Dr. Bachrach typically perform?
As a Pediatric Endocrinologist, procedures performed by Dr. Laura Bachrach may include:
- Adrenal Surgery
- Comparative Genomic Hybridization
- D and C / Vacuum Aspiration
- Diabetes Blood Sugar Management
- Diabetes Care - Kidney Disease Monitoring
- Diabetes Consultation
- Doppler Ultrasound
- Egg Freezing/ Fertility Preservation
Please contact Dr. Bachrach's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Bachrach accept my insurance?
Dr. Bachrach accepts most major insurance plans. Important: Please call our office at (408) 885-5000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Bachrach accept in Palo Alto, CA?
Dr. Bachrach in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
California Water Service Group
Conifer Health Solutions
CVS Health (formerly Aetna)
Santa Cruz County
State of California
Sutter Health
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Bachrach's office located?
Recognitions
Publications
Cost-effectiveness of Universal Serologic Screening to Prevent Nontraumatic Hip
, 2013
Correlates of low bone mass in children with generalized forms of epidermolysis bullosa
, 2011
Patterns of bone mineral acquisition in children with epidermolysis bullosa: a longitudil study
, 2011
Characterization of low bone mass in young patients with thalassemia by DXA
, 2011
Biopsychosocial variables associated with substantial bone mineral density loss during the use of
, 2010
Idequate Vitamin D Status in Adolescents with Substantial Bone Mineral Density
, 2010
Nutritiol Factors That Influence Change in Bone Density
, 2010
Recovery of bone mineral density
, 2010
Nutritiol Factors that Influence Change in Bone Density
, 2010
Intertiol longitudil pediatric reference standards for bone mineral content
, 2010
Clinical Review: Bisphosphote Use in Childhood Osteoporosis
, 2009
Effect of oral contraceptives on weight and body composition in young female runners
, 2008
Longitudil study of depot medroxyprogesterone acetate (Depo
, 2008
Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents
, 2008
Risk factors for stress fracture among young female cross-country runners
, 2007
Consensus and controversy regarding osteoporosis in the pediatric population.
, 2007
The effect of oral contraceptives on bone mass and stress fractures in female runners
, 2007
Bone mineral density in postmerchal adolescent girls in the United States
, 2007
Variable deficits of bone mineral despite chronic glucocorticoid therapy
, 2006
Sequential comparisons of one-month
, 2006
Measuring bone mass in children: Can we really do it?
, 2006
The relative contributions of lean tissue mass and fat mass to bone density in young women
, 2005
Osteoporosis and measurement of bone mass in children and adolescents
, 2005
Consensus statement: Guide to bone health and disease in cystic fibrosis
, 2005
Assessing bone health in children: who to test and what does it mean?
, 2005
Taking steps towards reducing osteoporosis in Duchenne Muscular Dystrophy
, 2005
Official positions of the Intertiol Society for Clinical Densitometry
, 2004
Bone health in children and adolescents
, 2004
Standards and guidelines for performing central dual-energy X
, 2004
Bone mineral density in pediatric transplant recipients
, 2003
Low-dose intravenous pamidrote reduces fractures in childhood osteoporosis
, 2003
Disordered eating, menstrual irregularity, and bone mineral density in female runners
, 2003
Comparison of calcaneus ultrasound and dual X-ray absorptiometry in children at risk of osteopenia
, 2003
Diet in midpuberty and sedentary activity in prepuberty predict peak bone mass
, 2003
Ethnic differences in bone mass of young women vary with method of assessment
, 2002
Calcaneus ultrasound measurements in a convenience sample of healthy youth
, 2001
Acquisition of optimal bane mass in childhood and adolescence
, 2001
Depot medroxyprogesterone acetate in teens: A risk for bone health?
, 2000
Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition
, 2000
Use of hormone replacement therapy to reduce the risk of osteopenia
, 2000
Mechanobiology of femoral neck structure during adolescence
, 2000
Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: A longitudil study
, 1999
tural history of growth hormone receptor deficiency
, 1999
A comparison of calcaneus ultrasound
, 1999
Influence of pre-adolescent diet on quantitative ultrasound measurements of the calcaneus in young
, 1999
Two measures of physical activity as predictors of bone mass in a young cohort
, 1998
Bone acquisition and loss in children and adults with cystic fibrosis: A longitudil study
, 1998
Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths
, 1997
Intakes of nutrients and foods relevant to bone health in ethnically diverse youths
, 1997
Determints of femoral neck structure during adolescence.
, 1997
Velocardiofacial syndrome presenting as hypocalcemia in early adolescence
, 1997
Correspondence between theoretical models
, 1997
Body mass is the primary determint of midfemoral bone acquisition during adolescent growth
, 1996
Differences in bone mineral in young Asian
, 1996
Determints of femoral geometry and structure during adolescent growth
, 1996
Correlates of osteopenia in patients with cystic fibrosis
, 1996
Validity of the body mass index as an indicator of adiposity
, 1996
BONE-MINERAL DENSITY DURING TREATMENT OF CENTRAL PRECOCIOUS PUBERTY
, 1995
THE BONE-MINERAL STATUS OF PATIENTS WITH MARFAN-SYNDROME
, 1995
A PHYSICIAN SURVEY OF THERAPY FOR EXERCISE-ASSOCIATED AMENORRHEA - A BRIEF REPORT
, 1995
LOADING FROM BODY-MASS DETERMINES BONE MASS AND STRUCTURE DURING ADOLESCENCE
, 1995
Osteopenia in Turner girls
, 1995
OSTEOPENIA IN ADULTS WITH CYSTIC-FIBROSIS
, 1994
LOW BONE-MINERAL DENSITY AT AXIAL AND APPENDICULAR SITES IN AMENORRHEIC ATHLETES
, 1993
TURNER SYNDROME ADOLESCENTS RECEIVING GROWTH-HORMONE ARE NOT OSTEOPENIC
, 1993
2-YEAR RESULTS OF TREATMENT WITH DEPOT LEUPROLIDE ACETATE FOR CENTRAL PRECOCIOUS PUBERTY
, 1992
CLINICAL AND ANTHROPOMETRIC CORRELATES OF BONE-MINERAL ACQUISITION IN HEALTHY ADOLESCENT GIRLS
, 1991
RECOVERY FROM OSTEOPENIA IN ADOLESCENT GIRLS WITH ANOREXIA-NERVOSA
, 1991
Thyrotropin inhibits while insulin
, 1991
DECREASED BONE-DENSITY IN ADOLESCENT GIRLS WITH ANOREXIA-NERVOSA
, 1990
Interaction of TSH, insulin and insulin
, 1990
INDUCTION OF ORNITHINE DECARBOXYLASE ACTIVITY BY GROWTH AND DIFFERENTIATION FACTORS IN FRTL-5 CELLS
, 1989
REGULATION OF THYROPEROXIDASE, THYROGLOBULIN AND IODIDE LEVELS IN SHEEP THYROID-CELLS BY TSH
, 1989
EFFECTS OF AMIODARONE DURING PREGNCY
, 1987
Role of non-TSH factors in thyroid cell growth.
, 1987
ROLE OF NON-TSH FACTORS IN THYROID CELL-GROWTH
, 1987
DISPARATE UPTAKE OF (TCO4)-TC-99M AND I-125 IN THYROID-CELLS IN CULTURE
, 1986
PHORBOL ESTERS STIMULATE GROWTH AND INHIBIT DIFFERENTIATION IN CULTURED THYROID-CELLS
, 1985
THE EFFECTS OF GROWTH-FACTORS AND SERUM ON D
, 1984
TRANS-PLACENTAL EFFECTS OF 3
, 1983
TREATMENT OF OVINE CRETINISM INUTERO WITH 3,5-DIMETHYL-3'-ISOPROPYL-L-THYRONINE
, 1982